Jackson Creek Investment Advisors LLC Makes New $1.35 Million Investment in Inspire Medical Systems, Inc. (NYSE:INSP)

Jackson Creek Investment Advisors LLC bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,461 shares of the company's stock, valued at approximately $1,348,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Dragoneer Investment Group LLC acquired a new stake in shares of Inspire Medical Systems during the fourth quarter worth $161,486,000. Congress Asset Management Co. grew its position in Inspire Medical Systems by 3,943.6% in the 1st quarter. Congress Asset Management Co. now owns 307,555 shares of the company's stock valued at $48,987,000 after buying an additional 299,949 shares in the last quarter. Marshall Wace LLP grew its position in Inspire Medical Systems by 1,775.3% in the 4th quarter. Marshall Wace LLP now owns 277,131 shares of the company's stock valued at $51,375,000 after buying an additional 262,353 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Inspire Medical Systems during the 4th quarter valued at about $47,604,000. Finally, Jacobs Levy Equity Management Inc. grew its stake in shares of Inspire Medical Systems by 869.9% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 210,160 shares of the company's stock worth $38,959,000 after purchasing an additional 188,492 shares during the last quarter. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Inspire Medical Systems news, Director Shawn Mccormick sold 360 shares of the stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $160.00, for a total transaction of $57,600.00. Following the completion of the sale, the director owned 24,046 shares of the company's stock, valued at approximately $3,847,360. This represents a 1.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 4.10% of the company's stock.

Inspire Medical Systems Stock Performance

Shares of NYSE INSP traded down $0.07 during mid-day trading on Friday, reaching $127.91. The company had a trading volume of 8,670 shares, compared to its average volume of 557,547. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $225.00. The firm has a market cap of $3.77 billion, a price-to-earnings ratio of 59.49, a PEG ratio of 1.95 and a beta of 1.25. The business's 50-day simple moving average is $136.73 and its 200 day simple moving average is $160.03.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.33. The company had revenue of $201.32 million for the quarter, compared to analysts' expectations of $194.89 million. Inspire Medical Systems had a return on equity of 10.00% and a net margin of 7.92%. The business's quarterly revenue was up 22.7% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.34) earnings per share. On average, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have commented on INSP shares. Stifel Nicolaus decreased their target price on shares of Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating for the company in a report on Monday, April 21st. Robert W. Baird raised their price target on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the stock an "outperform" rating in a report on Tuesday, May 6th. Royal Bank Of Canada cut their price objective on shares of Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. JPMorgan Chase & Co. dropped their price target on shares of Inspire Medical Systems from $235.00 to $195.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 6th. Finally, Wells Fargo & Company dropped their price target on shares of Inspire Medical Systems from $195.00 to $174.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $210.27.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.